SONIRE Therapeutics Inc.

SONIRE Therapeutics Inc. is developing a next-generation ultrasound-guided HIFU therapy system based on the technology and know-how developed at Tokyo Women's Medical University, Tohoku University, and Tokyo Medical University. HIFU therapy is expected as a new treatment that is non-invasive and has no radiation risk. Through the implementation of HIFU therapy for intractable cancers like pancreatic cancer, we aim to "Sonics brings new future to cancer patients", which is our wish in our company